Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

OSMT

Osmotica Pharmaceuticals (OSMT)

Osmotica Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OSMT
DateTimeSourceHeadlineSymbolCompany
11/08/20214:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/20214:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/08/20214:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
11/03/20214:31PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/22/20214:28PMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/14/20214:11PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/13/20214:45PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Closing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/12/20214:47PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/08/20215:14PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/07/20219:04AMGlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Debt Financing from Athyrium Capital Management of up to $100 MillionNASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/07/202112:31AMGlobeNewswire Inc.Osmotica Pharmaceuticals Announces Pricing of $35 Million Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/06/20215:26PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/06/20214:26PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc Announces Proposed Underwritten Public OfferingNASDAQ:OSMTOsmotica Pharmaceuticals PLC
10/06/20214:23PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/27/20218:47AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/22/20215:00PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at Cantor Virtual Global Healthcare Conference 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/20217:11AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/08/20217:02AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/03/20214:02PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
09/02/20215:00PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/30/20216:50AMGlobeNewswire Inc.Osmotica Pharmaceuticals plc Closes Sale of Legacy Business to Alora Pharmaceuticals, LLCNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/20/20215:22AMTipRanksGauging Osmotica Pharma’s Risk Factors Post Q2NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/16/20215:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/16/20214:53PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/16/20214:05PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc Reports Second Quarter 2021 Results and Provides Business UpdateNASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/12/20215:30PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc to Present at H.C. Wainwright Ophthalmology Virtual Conference on August 17, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
08/11/20217:00PMGlobeNewswire Inc.Osmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021NASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/30/20217:15AMGlobeNewswire Inc.Osmotica Subsidiary RVL Pharmaceuticals, Focused on Eye Care and Ocular Aesthetics, Strengthens and Expands Leadership TeamNASDAQ:OSMTOsmotica Pharmaceuticals PLC
06/30/20216:07AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OSMTOsmotica Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:OSMT